AMY EMERICK: Open Payments
NPI 1003400870 · COOKEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 49 payments from 12 companies in 2025. Trend: 2023 $1,526 · 2024 $1,435 · 2025 $1,090
Food & beverage: $1,090
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 14 | $332 |
| Corium, LLC | 8 | $178 |
| Neurocrine BioSciences, Inc. | 6 | $137 |
| E.R. Squibb & Sons, L.L.C. | 3 | $100 |
| ABBVIE INC. | 5 | $84 |
| Lundbeck LLC | 3 | $62 |
| Janssen Pharmaceuticals, Inc | 2 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
Products named: AUSTEDO XR, Azstarys, INGREZZA, UZEDY, COBENFY, REXULTI, VRAYLAR, SPRAVATO.
Industry payments across TN — which companies pay providers there.
